Try our Advanced Search for more refined results

Deals Rumor Mill: Dermapharm, Aramco, Life Healthcare

By Benjamin Horney (January 8, 2018, 4:30 PM EST) -- The family owners of Dermapharm AG are planning to take the German generic-drug maker public before the start of April, according to a Monday report from Reuters. Investment bank Berenberg has been hired to assist with the initial public offering, which is expected to value Dermapharm at upward of €1 billion ($1.2 billion), the report said. Reports in late 2015 said the family owners of the company were considering a sale of the business, though it now appears as if an IPO is the path being taken. Dermapharm makes treatments for skin diseases, along with products like allergy drugs, dietary supplements and suntan lotion....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!